Clinical trial

Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

NCT04895488

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-01-20

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2022-01-20Date precision: day

Registry last updated2024-02-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cognitive Impairment With Primary Psychotic Disorderunresolved

Negative Symptoms With Primary Psychotic Disorderunresolved

Interventions

VortioxetineDRUG · verified · RxNorm: vortioxetine

Usual Antipsychotic TreatmentDRUG

Sponsors & collaborators

Fundación Pública Andaluza para la gestión de la Investigación en Sevillalead sponsor

Mapped research locations

SevilleSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04895488 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.